Cannabix Technologies Inc (OTCMKTS: BLOZF) is back in the news. In a statement, the company announced that the Canadian Intellectual Property Office (CIPO) had granted it a patient. 

Information about the cannabis drug detection device patient

According to reports, Cannabix Technologies Inc has been attempting to have the patient registered in the company’s name ever since 16 April 2015. The company, in a statement, announced the Canadian Intellectual Property Office (CIPO) had granted patent No. 2887841 entitled, “Cannabis Drug Detection Device.” The company develops Cannabix Marijuana Breathalyzer devices that are used at workspaces and by law enforcement. In addition, a source shares that the company is involved in the research and development phase to introduce point-of-care breath testing technologies to detect ∆9-tetrahydrocannabinol (THC), a component of marijuana that is known to cause impairment.

THC Breath Analyzer (THCBA) is all set to be tested at a clinic in Northwestern, U.S.

According to reports, Cannabix Technologies Inc will dispatch its first THC Breath Analyzer (THCBA) in June if all falls in place. The Breath Analyzer will make its way to a clinic in Northwestern, U.S., where it will undergo beta testing. A source shared that beta testing the THCBA prototype aims to enhance user experience and improve administrator experience. In addition, it has come to light that the testing center where the Breath Analyzer test is to take place is reportedly one of the top facilities in the respective state. The THCBA is a drug screening equipment that is capable of testing the recent use of THC.  

An official from Cannabix Technologies Inc comments 

“In the last several months we have seen the states of Oregon, New Jersey, New York and Arizona legalize recreational use of marijuana and several other states like Virginia, New Mexico, Montana and Connecticut have taken steps to either legalize or decriminalize cannabis possession in some way. This has led to recent reports from AAA and IIHS outlining the impact of driving performance under the influence of cannabis. Furthermore, employers are re-examining their drug testing policies, procedures and tools. There is a massive sea-change happening in the U.S. related to cannabis use and Cannabix Technologies is at the forefront of developing the tools to aid public safety and create more relevant and fairer cannabis testing technology,” stated CEO Rav Mlait.